Molecule of the Month. Mipomersem sodium.
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001055:Apolipoproteins B / Q000235:genetics; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D009841:Oligonucleotides / Q000009:adverse effects / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000009:adverse effects / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D001055:Apolipoproteins B; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense; C524142:mipomersen